Explainer: Final steps in US review of COVID-19 vaccine
The Food and Drug Administration posted a positive review of the Pfizer vaccine on Tuesday and will hold a public hearing on Thursday. Next week, it will do the same thing for Moderna’s coronavirus vaccine candidate.
Share:
